Profound Medical (PROF) Revenue (2024 - 2026)

Profound Medical's Revenue history runs 3 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Revenue rose 103.62% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $18.6 million, a 53.82% increase from a year earlier, with the FY2025 full-year figure at $16.1 million, up 50.73% from the prior year.
• Revenue fell to $5.3 million in Q1 2026 per PROF's latest filing, from $6.0 million in the prior quarter.
• Across five years, Revenue topped out at $6.0 million in Q4 2025 and bottomed at $1.2 million in Q1 2024.
• The 3-year median for Revenue is $2.6 million (2025), against an average of $3.5 million.
• Biggest YoY gain for Revenue was 115.01% in 2025; the steepest drop was 13.21% in 2025.
• Year by year, Revenue stood at $5.0 million in 2024, then advanced by 20.36% to $6.0 million in 2025, then fell by 10.71% to $5.3 million in 2026.
• Per Business Quant, the three latest PROF Revenue figures stand at $5.3 million (Q1 2026), $6.0 million (Q4 2025), and $5.1 million (Q3 2025).